Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

Podcast TCTMD Talking Points

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

December 06, 2017

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

Presentation TCT 2017

PIONEER AF: Topline Findings and Practice Implications

Presenter: Robert A. Harrington, Evan A. Stein, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx

November 01, 2017

Presentation TCT 2017

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms IV

Presenter: C. Michael Gibson, Shelley Wood, Robert W. Yeh

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms III

Presenter: C. Michael Gibson, Shelley Wood, Sunil V. Rao

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms II

Presenter: C. Michael Gibson, Shelley Wood

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms I

Presenter: C. Michael Gibson, Shelley Wood, Mirvat Alasnag

November 01, 2017

Presentation TCT 2017

Twitter, Facebook, and Instagram 101: The Basics

Presenter: C. Michael Gibson, Shelley Wood, Sheila Sahni

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Featured Lecture: The Nuances and Consequences of Data Sharing Mandate a Measured Strategy of Collaboration

Presenter: Robert A. Harrington, Richard E. Kuntz, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates

October 30, 2017

Advertisement

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

Baim Institute Names Dr. C. Michael Gibson As CEO

Live From Denver: TCT 2017, Day Four

PIONEER AF: Topline Findings and Practice Implications

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Case Examples of Interventionalists Social Medial Platforms IV

Case Examples of Interventionalists Social Medial Platforms III

Case Examples of Interventionalists Social Medial Platforms II

Case Examples of Interventionalists Social Medial Platforms I

Twitter, Facebook, and Instagram 101: The Basics

Live From Denver: TCT 2017, Day Three

Featured Lecture: The Nuances and Consequences of Data Sharing Mandate a Measured Strategy of Collaboration

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content